Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

for the Dutch Pancreatic Cancer Group

doi:https://doi.org/10.1186/s12885-023-10521-1

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

Files

s12885_023_10521_1.pdf (650.79 KB)

Publication date

2023-01-20

Authors

for the Dutch Pancreatic Cancer Group

DOI

https://doi.org/10.1186/s12885-023-10521-1

Document Type

Comment

Metadata

Show full item record

Collections

UMC Repository

License

cc_by

Abstract

Correction: Trials 23, 913 (2022) https://doi.org/10.1186/s13063-022-06829-

Keywords

Oncology, Genetics, Cancer Research

Citation

for the Dutch Pancreatic Cancer Group 2023, 'Correction : Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)', BMC Cancer, vol. 23, no. 1, 70, pp. 1-1. https://doi.org/10.1186/s12885-023-10521-1

URI

https://dspace.library.uu.nl/handle/1874/448547